Roivant Sciences Ltd. (ROIV)
USD 9.0
(-4.86%)
USD 9.0
(-4.86%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 4.24 Billion USD | 493.67% |
| 2023 | 4.24 Billion USD | 11.07% |
| 2022 | -1.17 Billion USD | -13.15% |
| 2021 | -1.35 Billion USD | -101.14% |
| 2020 | -1.07 Billion USD | 28.87% |
| 2019 | -532.42 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | 4.24 Billion USD | 493.67% |
| 2024 Q1 | -276.41 Million USD | 54.82% |
| 2024 Q2 | 276.45 Million USD | -184.32% |
| 2024 Q3 | 5.06 Billion USD | 1730.64% |
| 2024 Q4 | -266 Million USD | -105.26% |
| 2023 Q1 | -282.3 Million USD | -6.42% |
| 2023 FY | -1.07 Billion USD | 11.07% |
| 2023 Q4 | -234.16 Million USD | 16.47% |
| 2023 Q3 | -280.32 Million USD | 0.16% |
| 2023 Q2 | -280.76 Million USD | 0.55% |
| 2022 Q4 | -265.28 Million USD | -7.83% |
| 2022 FY | -1.21 Billion USD | -13.15% |
| 2022 Q3 | -246.02 Million USD | 64.05% |
| 2022 Q2 | -684.42 Million USD | -343.32% |
| 2022 Q1 | -154.38 Million USD | 71.45% |
| 2021 Q1 | -114.45 Million USD | -38.73% |
| 2021 Q2 | -156.54 Million USD | -36.77% |
| 2021 Q4 | -540.83 Million USD | -108.76% |
| 2021 Q3 | -259.07 Million USD | -65.5% |
| 2021 FY | -1.07 Billion USD | -101.14% |
| 2020 Q4 | -82.5 Million USD | 0.0% |
| 2020 FY | -532.42 Million USD | 28.87% |
| 2019 FY | -748.49 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -237.2 Million USD | 1888.318% |
| Alkermes plc | 414.12 Million USD | -924.34% |
| Agenus Inc. | -159.54 Million USD | 2758.754% |
| Aptorum Group Limited | -10.52 Million USD | 40410.586% |
| Ardelyx, Inc. | -63.27 Million USD | 6803.989% |
| Dyadic International, Inc. | -8.22 Million USD | 51644.964% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | 355973.826% |
| Lantern Pharma Inc. | -17.87 Million USD | 23828.146% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | 21215.281% |
| Novavax, Inc. | -566.51 Million USD | 848.797% |
| Janux Therapeutics, Inc. | -72.97 Million USD | 5912.653% |
| Pyxis Oncology, Inc. | -82.19 Million USD | 5260.855% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | 21945.212% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | 40259.197% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | 8084.764% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | 1214.865% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | 17552.11% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | 11301.817% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | 3388.69% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | 5155.195% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 24286.191% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | 9738.755% |
| Clearside Biomedical, Inc. | -24.84 Million USD | 17174.61% |
| C4 Therapeutics, Inc. | -139.03 Million USD | 3151.13% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | 1603.328% |
| AlloVir, Inc. | -181.33 Million USD | 2439.377% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | 2169.256% |
| VYNE Therapeutics Inc. | -29.25 Million USD | 14598.653% |
| Bicycle Therapeutics plc | -189.94 Million USD | 2333.275% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | 2569.418% |
| ChromaDex Corporation | -5.59 Million USD | 75863.815% |
| Chimerix, Inc. | -93.06 Million USD | 4658.122% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | 9510.537% |
| Caribou Biosciences, Inc. | -116.05 Million USD | 3755.051% |
| CRISPR Therapeutics AG | -222.53 Million USD | 2006.198% |
| Precision BioSciences, Inc. | -43.73 Million USD | 9799.14% |
| Fate Therapeutics, Inc. | -190.51 Million USD | 2326.651% |
| Fortress Biotech, Inc. | -142.34 Million USD | 3080.158% |
| Fortress Biotech, Inc. | -142.34 Million USD | 3080.158% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | 4442.146% |
| ImmuCell Corporation | -5.74 Million USD | 73898.859% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | 3255.581% |
| Immix Biopharma, Inc. | -16.14 Million USD | 26380.815% |
| Incyte Corporation | 620.52 Million USD | -583.617% |
| Innoviva, Inc. | 176.7 Million USD | -2300.566% |
| IO Biotech, Inc. | -91.44 Million USD | 4738.973% |
| Jaguar Health, Inc. | -34.29 Million USD | 12470.64% |
| Keros Therapeutics, Inc. | -169.94 Million USD | 2596.17% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | -35421.822% |
| ContextLogic Inc. | -328 Million USD | 1393.298% |
| MiMedx Group, Inc. | 37.11 Million USD | -11329.076% |
| MEI Pharma, Inc. | 14.54 Million USD | -29070.788% |
| NextCure, Inc. | -67.63 Million USD | 6371.739% |
| Onconetix, Inc. | -36.03 Million USD | 11872.065% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | 10269.286% |
| Opthea Limited | -191.84 Million USD | 2311.195% |
| Psyence Biomedical Ltd. | -2.75 Million USD | 154252.826% |
| Vaxcyte, Inc. | -468.04 Million USD | 1006.334% |
| PDS Biotechnology Corporation | -43.04 Million USD | 9954.787% |
| Precigen, Inc. | -88.92 Million USD | 4870.437% |
| Pharming Group N.V. | -4.87 Million USD | 87034.681% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | 2635.393% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | 14356.002% |
| PureTech Health plc | -146.19 Million USD | 3001.536% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | 20801.85% |
| Avidity Biosciences, Inc. | -235.59 Million USD | 1900.531% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | 17552.11% |
| Sangamo Therapeutics, Inc. | -274 Million USD | 1648.153% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | 14575.4% |
| Acelyrin, Inc. | -422.06 Million USD | 1105.065% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | 32896848.647% |
| Summit Therapeutics Inc. | -89.73 Million USD | 4827.218% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | 11545.111% |
| Senti Biosciences, Inc. | -92.72 Million USD | 4674.737% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | 3796.005% |
| Elevation Oncology, Inc. | -45.44 Million USD | 9434.395% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | 12479.304% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 107709.446% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | 134256.104% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | 12946.419% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | 50000.2% |
| Wave Life Sciences Ltd. | -67.99 Million USD | 6338.626% |
| Seer, Inc. | -103.46 Million USD | 4200.032% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | 6550.852% |
| Aadi Bioscience, Inc. | -71.93 Million USD | 5997.177% |
| ESSA Pharma Inc. | -32.13 Million USD | 13300.978% |
| GlycoMimetics, Inc. | -39.27 Million USD | 10900.724% |
| GT Biopharma, Inc. | -13.57 Million USD | 31346.435% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | 2035.041% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | 9270.737% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | -4786.44% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | 7573.733% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | 8335.965% |
| Alzamend Neuro, Inc. | -9.93 Million USD | 42786.331% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | 941.144% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | 61596.318% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | 8468.051% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | 1733.687% |
| Aptose Biosciences Inc. | -52.35 Million USD | 8202.254% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | 29516.008% |
| Soligenix, Inc. | -7.69 Million USD | 55205.859% |
| Century Therapeutics, Inc. | -146.54 Million USD | 2994.665% |
| Kura Oncology, Inc. | -165.8 Million USD | 2658.452% |
| TScan Therapeutics, Inc. | -93.45 Million USD | 4638.954% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | 51091.898% |
| Ocean Biomedical, Inc. | -2.48 Million USD | 171036.063% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | 65522.825% |
| Autolus Therapeutics plc | -195.02 Million USD | 2275.081% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | 5110.827% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | 5858.758% |
| Eterna Therapeutics Inc. | -21.13 Million USD | 20171.048% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | 1968.441% |
| GRI Bio, Inc. | -11.38 Million USD | 37353.148% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | 94038.966% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | 3333.416% |
| IGM Biosciences, Inc. | -263.46 Million USD | 1710.112% |
| INmune Bio, Inc. | -29.74 Million USD | 14363.192% |
| Heron Therapeutics, Inc. | -110.61 Million USD | 3934.937% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | 11241.117% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | 26646.844% |
| Entero Therapeutics, Inc. | -15.77 Million USD | 26997.867% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | 7042.97% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | 4045.254% |
| Atara Biotherapeutics, Inc. | -276 Million USD | 1636.929% |
| Coherus BioSciences, Inc. | -203.19 Million USD | 2187.617% |
| Verastem, Inc. | -92.08 Million USD | 4706.681% |
| Abeona Therapeutics Inc. | -47.13 Million USD | 9099.716% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | 2403.628% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | 3683.389% |
| Histogen Inc. | -10.64 Million USD | 39957.333% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | 27517.444% |
| Surrozen, Inc. | -45.78 Million USD | 9366.09% |
| Organovo Holdings, Inc. | -15.08 Million USD | 28218.892% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | 83436.333% |
| Ovid Therapeutics Inc. | -59.28 Million USD | 7255.721% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | 8370.004% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | 16880.127% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | 55675.832% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | 2576.612% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | 8855.821% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | 5524.226% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | 27969.91% |
| Apollomics, Inc. | -54.83 Million USD | 7836.105% |
| Amarin Corporation plc | -67.58 Million USD | 6376.286% |
| Mesoblast Limited | -58.79 Million USD | 7315.049% |
| Turnstone Biologics Corp. | -59.03 Million USD | 7285.96% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | 2662.687% |
| Synaptogenix, Inc. | -8.31 Million USD | 51123.46% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | 29182.792% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | 4726.426% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | 88632.737% |
| Monopar Therapeutics Inc. | -8.83 Million USD | 48134.233% |
| Exelixis, Inc. | 170.88 Million USD | -2382.381% |
| Better Therapeutics, Inc. | -38.26 Million USD | 11186.76% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | 2835.673% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | 920.314% |
| NLS Pharmaceutics AG | -11.8 Million USD | 36027.783% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | 52848.888% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | 14243.353% |
| Gritstone bio, Inc. | -154.63 Million USD | 2843.262% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | 6260.259% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | 24873.714% |
| Avid Bioservices, Inc. | -18.67 Million USD | 22811.297% |
| Insmed Incorporated | -709.62 Million USD | 697.782% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | 27136.796% |
| MediWound Ltd. | -15.29 Million USD | 27843.728% |
| OmniAb, Inc. | -69.41 Million USD | 6210.742% |
| Alector, Inc. | -151.74 Million USD | 2895.582% |
| Seres Therapeutics, Inc. | -107.98 Million USD | 4028.411% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | 8234.571% |
| Zai Lab Limited | -366.57 Million USD | 1257.209% |
| Revance Therapeutics, Inc. | -316.77 Million USD | 1439.117% |
| Aura Biosciences, Inc. | -84.99 Million USD | 5091.136% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | 1827.916% |
| Immunic, Inc. | -99.22 Million USD | 4375.235% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | 3063.171% |
| Veracyte, Inc. | -85.79 Million USD | 5044.363% |
| InMed Pharmaceuticals Inc. | - USD | -Infinity% |
| FibroGen, Inc. | -281.81 Million USD | 1605.248% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | 29952.329% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | 61686.072% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | 22672.78% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | -633.177% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | 16766.075% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | -10832.467% |
| TG Therapeutics, Inc. | 20.63 Million USD | -20459.376% |
| Galecto, Inc. | -39.9 Million USD | 10730.287% |
| Calithera Biosciences, Inc. | -42.07 Million USD | 10182.274% |
| Fortrea Holdings Inc. | 63.1 Million USD | -6622.688% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | 3120.411% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | 14789.438% |
| XBiotech Inc. | -37.51 Million USD | 11409.027% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | 6260.259% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | 6420.048% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | 4031.214% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | 16623.902% |
| Theravance Biopharma, Inc. | -53.29 Million USD | 8059.949% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 845.249% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | 5504.393% |
| Vaxxinity, Inc. | -58.28 Million USD | 7378.058% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | 4190.307% |
| Gain Therapeutics, Inc. | -22.25 Million USD | 19162.556% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | 5008.832% |
| NexImmune, Inc. | -29.19 Million USD | 14631.194% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | 75578.939% |
| Marker Therapeutics, Inc. | -14.58 Million USD | 29192.01% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | -4.816% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | 16762.147% |
| Scopus BioPharma Inc. | -11.71 Million USD | 36310.504% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | 3438.54% |
| Ainos, Inc. | -13.2 Million USD | 32220.921% |
| Pluri Inc. | -22.15 Million USD | 19244.399% |
| Prothena Corporation plc | -191.03 Million USD | 2320.532% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | 3173.078% |
| Celularity Inc. | -192.28 Million USD | 2306.086% |
| Rallybio Corporation | -78.93 Million USD | 5474.266% |
| Cue Biopharma, Inc. | -52.14 Million USD | 8234.415% |
| MeiraGTx Holdings plc | -137.06 Million USD | 3194.984% |
| Omeros Corporation | -164.53 Million USD | 2678.263% |
| Humacyte, Inc. | -100.04 Million USD | 4340.023% |
| Immunocore Holdings plc | -59.64 Million USD | 7211.63% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | 22956.921% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | 17426.373% |
| Blueprint Medicines Corporation | -486.27 Million USD | 972.346% |
| CalciMedica, Inc. | -21.87 Million USD | 19492.073% |
| Cabaletta Bio, Inc. | -74.66 Million USD | 5781.779% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | 3326.236% |
| Scholar Rock Holding Corporation | -171.29 Million USD | 2576.439% |
| Sana Biotechnology, Inc. | -326.9 Million USD | 1397.649% |
| Pulmatrix, Inc. | -14.74 Million USD | 28878.942% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | 11967.439% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | 4873.497% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | 923.227% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | 6379.723% |
| Cytokinetics, Incorporated | -496.2 Million USD | 954.892% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | 12424.635% |
| Nutriband Inc. | -4.87 Million USD | 87170.616% |
| Protara Therapeutics, Inc. | -43.61 Million USD | 9826.494% |
| Vor Biopharma Inc. | -126.03 Million USD | 3465.718% |
| Evogene Ltd. | -26.39 Million USD | 16173.722% |
| ProKidney Corp. | -151.52 Million USD | 2899.604% |
| Applied Therapeutics, Inc. | -64.53 Million USD | 6673.202% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | 55246.679% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 798.424% |
| CorMedix Inc. | -48.95 Million USD | 8764.64% |
| BioLineRx Ltd. | -49.69 Million USD | 8636.274% |
| Tango Therapeutics, Inc. | -114.17 Million USD | 3815.428% |
| Galectin Therapeutics Inc. | -38.07 Million USD | 11242.089% |
| Atai Life Sciences N.V. | -125.47 Million USD | 3480.874% |
| Renovaro Biosciences Inc. | -81.63 Million USD | 5296.047% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | 5310.746% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | 1803.703% |
| Sagimet Biosciences Inc. | -30.74 Million USD | 13899.662% |
| MediciNova, Inc. | -9.9 Million USD | 42947.5% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | 3456.742% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | 58671.488% |
| GeoVax Labs, Inc. | -26.74 Million USD | 15962.191% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | 1929.835% |
| Biomea Fusion, Inc. | -126.13 Million USD | 3463.076% |
| PTC Therapeutics, Inc. | -349.4 Million USD | 1314.079% |
| Mereo BioPharma Group plc | -28.41 Million USD | 15028.266% |
| Cullinan Oncology, Inc. | -191.08 Million USD | 2319.916% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | 1944.724% |
| Absci Corporation | -115.51 Million USD | 3772.264% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | 15476.866% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | 3858.42% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | 1851.727% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | 16936.069% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | 2139.49% |
| Allakos Inc. | -196.05 Million USD | 2263.676% |
| Imunon, Inc. | -21.03 Million USD | 20270.848% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | 3933.239% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | -3854.08% |
| BioAtla, Inc. | -129.68 Million USD | 3370.965% |
| NLS Pharmaceutics AG | -11.8 Million USD | 36027.783% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | 26875.333% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | 1394.335% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | 10258.571% |
| XOMA Corporation | -41.84 Million USD | 10236.723% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | 4130.917% |
| Cara Therapeutics, Inc. | -121.49 Million USD | 3591.515% |
| aTyr Pharma, Inc. | -54.91 Million USD | 7824.132% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | 4952.066% |
| Akero Therapeutics, Inc. | -172.87 Million USD | 2553.876% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | 1767.131% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | 19861.558% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | 51751.559% |
| Akari Therapeutics, Plc | -16.8 Million USD | 25341.081% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | 47970264.073% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | -1156.618% |
| Lexaria Bioscience Corp. | -6.53 Million USD | 65021.973% |
| UroGen Pharma Ltd. | -65.53 Million USD | 6572.803% |
| Sutro Biopharma, Inc. | -89.27 Million USD | 4851.468% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | 58505.741% |
| Orgenesis Inc. | -53.63 Million USD | 8008.897% |
| Entera Bio Ltd. | -8.89 Million USD | 47811.349% |
| GH Research PLC | -41.22 Million USD | 10390.66% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | 16600.762% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | 5207.601% |
| Xencor, Inc. | -138.63 Million USD | 3159.757% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | 82396.007% |
| Replimune Group, Inc. | -234.77 Million USD | 1906.859% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | 19838.459% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | 30504.358% |
| Lexaria Bioscience Corp. | -6.53 Million USD | 65021.973% |
| Portage Biotech Inc. | -18.25 Million USD | 23340.103% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | 58671.488% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | 4141.516% |
| OncoCyte Corporation | -25.13 Million USD | 16976.257% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | 37623.836% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | 37125.342% |
| Purple Biotech Ltd. | 22.27 Million USD | -18947.263% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | 56569.862% |
| scPharmaceuticals Inc. | -55.39 Million USD | 7757.621% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | 22547.269% |
| HilleVax, Inc. | -133.34 Million USD | 3281.234% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | 35306.374% |
| Tharimmune, Inc. | -9.45 Million USD | 44964.276% |
| Genprex, Inc. | -31.07 Million USD | 13750.646% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | 2354.065% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | 13619.508% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | 554611.895% |
| Virios Therapeutics, Inc. | -5.44 Million USD | 77979.183% |
| OKYO Pharma Limited | -15.74 Thousand USD | 26933996.645% |
| Savara Inc. | -60 Million USD | 7169.202% |
| Curis, Inc. | -48.33 Million USD | 8876.827% |
| Daré Bioscience, Inc. | -30.83 Million USD | 13854.969% |
| Carmell Therapeutics Corporation | -5.21 Million USD | 81407.041% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | 58393.473% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | 15667.031% |
| BeiGene, Ltd. | -1.2 Billion USD | 451.237% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | 21374.649% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | 970.72% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | 4629.552% |
| Erasca, Inc. | -141.52 Million USD | 3097.362% |
| bluebird bio, Inc. | -244.26 Million USD | 1836.666% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | 93805.332% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | -2081.647% |
| DBV Technologies S.A. | -76.43 Million USD | 5650.052% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | 93805.332% |
| Moderna, Inc. | -4.23 Billion USD | 200.071% |
| Vincerx Pharma, Inc. | -42.6 Million USD | 10055.681% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | 66798.365% |
| Molecular Templates, Inc. | -10.46 Million USD | 40631.397% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | 6409.05% |
| Travere Therapeutics, Inc. | -376.74 Million USD | 1225.968% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | 3060.007% |
| Spruce Biosciences, Inc. | -51.99 Million USD | 8258.821% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | 2844.895% |
| Cogent Biosciences, Inc. | -208.13 Million USD | 2138.157% |
| MacroGenics, Inc. | -168.24 Million USD | 2621.348% |
| RenovoRx, Inc. | -11.39 Million USD | 37323.728% |
| Adicet Bio, Inc. | -152.03 Million USD | 2890.102% |
| Prime Medicine, Inc. | -191.29 Million USD | 2317.561% |
| Aditxt, Inc. | -26.06 Million USD | 16376.367% |
| Adagene Inc. | -23.71 Million USD | 17983.811% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 58129.537% |
| Quantum-Si incorporated | -111.17 Million USD | 3915.758% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | 13503.741% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | 29199.215% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | -3376.663% |
| SciSparc Ltd. | -5.77 Million USD | 73580.27% |
| Vericel Corporation | -6.46 Million USD | 65725.248% |
| Revelation Biosciences, Inc. | -8.65 Million USD | 49102.895% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | 18448.157% |
| Generation Bio Co. | -138.56 Million USD | 3161.435% |
| Astria Therapeutics, Inc. | -83.03 Million USD | 5209.016% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | 5006.334% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | 1859.435% |
| Invivyd, Inc. | -207.78 Million USD | 2141.561% |
| Relay Therapeutics, Inc. | -373 Million USD | 1237.27% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | 45331.265% |
| Spero Therapeutics, Inc. | 21.48 Million USD | -19647.758% |
| Artelo Biosciences, Inc. | -10.28 Million USD | 41336.668% |
| 2seventy bio, Inc. | -216.7 Million USD | 2057.525% |
| ADMA Biologics, Inc. | 21.63 Million USD | -19509.911% |
| Clene Inc. | -40.54 Million USD | 10563.779% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | 17717.912% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | 7841.47% |
| GeoVax Labs, Inc. | -26.74 Million USD | 15962.191% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | 1311.797% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | 11648.551% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | -26285.619% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | 4190.583% |
| Finch Therapeutics Group, Inc. | -34 Million USD | 12575.784% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | 2591.23% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 719.901% |
| Evaxion Biotech A/S | -22.19 Million USD | 19210.763% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | 5249.202% |
| Verve Therapeutics, Inc. | -223.12 Million USD | 2001.192% |
| Trevena, Inc. | -35.28 Million USD | 12121.129% |
| Surrozen, Inc. | -45.78 Million USD | 9366.09% |
| Tyra Biosciences, Inc. | -79.94 Million USD | 5406.168% |
| Cingulate Inc. | -22.75 Million USD | 18738.695% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | -56520.609% |
| Unity Biotechnology, Inc. | -44.66 Million USD | 9596.98% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | 51618.659% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | 4236.212% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | 5880.967% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | 6933.805% |
| Clearmind Medicine Inc. | -8.74 Million USD | 48628.156% |
| Kronos Bio, Inc. | -121.83 Million USD | 3581.914% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | 5667.242% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | 144731.357% |
| Viking Therapeutics, Inc. | -100.82 Million USD | 4307.222% |
| Statera Biopharma, Inc. | -98.34 Million USD | 4413.455% |
| ImmunityBio, Inc. | -362.25 Million USD | 1271.019% |
| Korro Bio, Inc. | -84.53 Million USD | 5118.118% |
| Kineta, Inc. | -15.72 Million USD | 27079.686% |
| BioVie Inc. | -32.17 Million USD | 13282.32% |
| Codexis, Inc. | -68.06 Million USD | 6331.935% |
| Celularity Inc. | -192.28 Million USD | 2306.086% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | 2005.599% |
| Celcuity Inc. | -66.23 Million USD | 6504.945% |
| Virax Biolabs Group Limited | -6.49 Million USD | 65397.216% |
| Cibus, Inc. | -318.88 Million USD | 1430.273% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | 9965.153% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | 12634.027% |
| IN8bio, Inc. | -30.33 Million USD | 14082.978% |
| Kodiak Sciences Inc. | -277.32 Million USD | 1629.641% |
| Annexon, Inc. | -143.72 Million USD | 3051.522% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | 3526.756% |
| Assembly Biosciences, Inc. | -64.64 Million USD | 6661.916% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | 18194.25% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | 1299.224% |
| Eyenovia, Inc. | -25.4 Million USD | 16796.613% |
| Puma Biotechnology, Inc. | 32.64 Million USD | -12896.373% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | 76367.817% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | 5460.616% |
| Arcellx, Inc. | -89.88 Million USD | 4819.644% |
| Cardiff Oncology, Inc. | -45.41 Million USD | 9441.179% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | 3191.691% |
| Regulus Therapeutics Inc. | -31.1 Million USD | 13735.977% |
| Moolec Science SA | -6.65 Million USD | 63853.236% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | 7038.428% |
| Geron Corporation | -193.94 Million USD | 2287.238% |
| LAVA Therapeutics N.V. | -43.25 Million USD | 9907.449% |
| Royalty Pharma plc | 1.49 Billion USD | -184.289% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | 2684.043% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | 45576.811% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | 19474.659% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | 2581.335% |
| Humacyte, Inc. | -100.04 Million USD | 4340.023% |
| Structure Therapeutics Inc. | -102.77 Million USD | 4227.478% |
| 89bio, Inc. | -151.2 Million USD | 2905.492% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | 5393.785% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | 29274.801% |
| Genelux Corporation | -24.16 Million USD | 17654.38% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | 12604.837% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | 2569.878% |
| Notable Labs, Ltd. | -14.65 Million USD | 29041.912% |
| Liquidia Corporation | -73.38 Million USD | 5880.573% |
| Mustang Bio, Inc. | -50.72 Million USD | 8462.607% |
| Immunovant, Inc. | -282.7 Million USD | 1600.488% |
| Quantum-Si incorporated | -111.17 Million USD | 3915.758% |
| Arbutus Biopharma Corporation | -78.1 Million USD | 5531.31% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | 20046.471% |
| Vera Therapeutics, Inc. | -102.01 Million USD | 4258.35% |
| Acasti Pharma Inc. | -11.31 Million USD | 37600.141% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | 18607.031% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | 26646.844% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | 2081.75% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | 115715.502% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | 26802.858% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | 14648.877% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | 10350.377% |
| PepGen Inc. | -84.76 Million USD | 5104.384% |
| Moleculin Biotech, Inc. | -29.63 Million USD | 14416.142% |
| United Therapeutics Corporation | 1.18 Billion USD | -258.006% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 18626.514% |
| Solid Biosciences Inc. | -104.31 Million USD | 4166.545% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | 13029.776% |
| Immuneering Corporation | -58.41 Million USD | 7362.124% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | 83436.333% |
| Silo Pharma, Inc. | -3.85 Million USD | 110122.43% |
| Belite Bio, Inc | -31.66 Million USD | 13495.276% |
| XOMA Corporation | -41.84 Million USD | 10236.723% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | 6382.607% |
| Bionomics Limited | -17.89 Billion USD | 123.709% |
| Apogee Therapeutics, Inc. | -93 Million USD | 4661.16% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | -11789.058% |
| uniQure N.V. | -282.87 Million USD | 1599.629% |
| Cassava Sciences, Inc. | -105.95 Million USD | 4103.526% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 58129.537% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | 3375.587% |
| Forte Biosciences, Inc. | -32.48 Million USD | 13157.982% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | 51154.773% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | 14531.08% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | 76367.817% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | 29952.329% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | 47822.083% |
| Altimmune, Inc. | -95.92 Million USD | 4522.037% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | 5871.922% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | -11789.058% |
| Compugen Ltd. | -12.99 Million USD | 32750.985% |
| Peak Bio, Inc. | -1356.23 USD | 312780085.696% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | 8651.762% |
| Benitec Biopharma Inc. | -22.49 Million USD | 18961.787% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | 1850.707% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | 14360.795% |
| Zura Bio Limited | -62.63 Million USD | 6872.272% |
| PolyPid Ltd. | -22.86 Million USD | 18650.82% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | 26163.013% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | 14360.795% |
| Instil Bio, Inc. | -159.16 Million USD | 2765.102% |
| argenx SE | -425.04 Million USD | 1098.006% |
| Immunome, Inc. | -109.53 Million USD | 3972.926% |
| Compass Therapeutics, Inc. | -50.36 Million USD | 8522.882% |
| Verona Pharma plc | -67.83 Million USD | 6353.811% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | 16377.882% |
| Shattuck Labs, Inc. | -91.95 Million USD | 4713.043% |
| CervoMed Inc. | -7.81 Million USD | 54395.06% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | 5902.238% |
| Plus Therapeutics, Inc. | -13.32 Million USD | 31944.576% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | 8905.613% |
| Moolec Science SA | -6.65 Million USD | 63853.236% |
| Enveric Biosciences, Inc. | -16.44 Million USD | 25889.777% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | 3236.967% |
| AnaptysBio, Inc. | -164.41 Million USD | 2680.129% |
| Design Therapeutics, Inc. | -78.19 Million USD | 5525.267% |
| Leap Therapeutics, Inc. | -87.04 Million USD | 4973.584% |
| NeurAxis, Inc. | -6.66 Million USD | 63750.974% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | 10574.372% |
| Lumos Pharma, Inc. | -36.61 Million USD | 11685.776% |
| Achilles Therapeutics plc | -75.25 Million USD | 5736.856% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | 16377.882% |
| 180 Life Sciences Corp. | -13.47 Million USD | 31574.799% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | -82168.428% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | 144731.357% |
| Nutriband Inc. | -4.87 Million USD | 87170.616% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | 3929.225% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | 7750.302% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | 8444.512% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | 6517.67% |
| MoonLake Immunotherapeutics | -54.12 Million USD | 7937.719% |
| Palisade Bio, Inc. | -13.07 Million USD | 32556.129% |
| Tourmaline Bio, Inc. | -45.4 Million USD | 9441.796% |
| Beam Therapeutics Inc. | -176.48 Million USD | 2503.613% |
| Neurogene Inc. | -55.58 Million USD | 7731.859% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | 3986.267% |
| AEON Biopharma, Inc. | -48.42 Million USD | 8859.248% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | 4486.326% |
| Sesen Bio, Inc. | -25.9 Million USD | 16472.751% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | 5178.495% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | 33801.844% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | 1021.058% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | 5955.984% |
| Athira Pharma, Inc. | -125.46 Million USD | 3481.008% |
| Vaccinex, Inc. | -22.88 Million USD | 18636.229% |
| HCW Biologics Inc. | -25.71 Million USD | 16594.885% |
| XOMA Corporation | -41.84 Million USD | 10236.723% |
| Nektar Therapeutics | -137.42 Million USD | 3186.786% |
| Arvinas, Inc. | -401.5 Million USD | 1156.542% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | 47970264.073% |
| Merus N.V. | -156.54 Million USD | 2809.74% |
| Omega Therapeutics, Inc. | -100.26 Million USD | 4330.973% |
| Quince Therapeutics, Inc. | -34.62 Million USD | 12353.079% |
| Rezolute, Inc. | -70.42 Million USD | 6123.623% |
| Clene Inc. | -40.54 Million USD | 10563.779% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | 25999.946% |
| BeyondSpring Inc. | -23.11 Million USD | 18452.583% |
| Synlogic, Inc. | -55.16 Million USD | 7790.245% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | 23760.081% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | 39290.835% |
| Peak Bio, Inc. | -1356.23 USD | 312780085.696% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | 10573.338% |
| Krystal Biotech, Inc. | -109.72 Million USD | 3965.973% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | 3374.677% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | 1336.692% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | 89481.753% |
| MannKind Corporation | 8.67 Million USD | -48782.415% |
| Ikena Oncology, Inc. | -75.41 Million USD | 5724.748% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | 44072.385% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | 6409.707% |
| Gossamer Bio, Inc. | -183.75 Million USD | 2408.467% |
| CohBar, Inc. | -12.38 Million USD | 34342.124% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | 8462.937% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | 15476.866% |
| Legend Biotech Corporation | -439.48 Million USD | 1065.224% |
| Mural Oncology plc | -194.63 Million USD | 2279.439% |
| Biora Therapeutics, Inc. | -67.14 Million USD | 6417.883% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | 26374.048% |
| Disc Medicine, Inc. | -91.12 Million USD | 4755.162% |
| Champions Oncology, Inc. | -7.35 Million USD | 57767.428% |
| REGENXBIO Inc. | -268.12 Million USD | 1682.086% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | 39677.738% |
| Anavex Life Sciences Corp. | -55.75 Million USD | 7708.178% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | 10987.952% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | 3809.45% |
| Vaxart, Inc. | -83.34 Million USD | 5189.585% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | 49888.873% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | 10012.623% |
| Cellectis S.A. | -106.62 Million USD | 4078.407% |
| Longeveron Inc. | -21.02 Million USD | 20272.219% |
| Repare Therapeutics Inc. | -116.22 Million USD | 3749.862% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | 1683.882% |
| Inozyme Pharma, Inc. | -75.64 Million USD | 5707.794% |
| Revolution Medicines, Inc. | -487.18 Million USD | 970.72% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | 63870.535% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | 9751.035% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | 5787.111% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | 6191.787% |
| Anixa Biosciences, Inc. | -11.01 Million USD | 38625.257% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 1.52% |
| Denali Therapeutics Inc. | -196.69 Million USD | 2256.603% |
| Revelation Biosciences, Inc. | -8.65 Million USD | 49102.895% |
| Veru Inc. | -93.78 Million USD | 4623.263% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | 18283.445% |
| Cingulate Inc. | -22.75 Million USD | 18738.695% |
| Passage Bio, Inc. | -108.38 Million USD | 4013.696% |
| Context Therapeutics Inc. | -25.07 Million USD | 17018.921% |
| Exicure, Inc. | -14.99 Million USD | 28387.65% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | 2158.592% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | 10548.83% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | 43755.897% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | 2400.979% |
| Nuvalent, Inc. | -149.49 Million USD | 2937.621% |
| ABVC BioPharma, Inc. | -8.21 Million USD | 51727.96% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | 4880.76% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | 20519.832% |
| OmniAb, Inc. | -69.41 Million USD | 6210.742% |
| Anew Medical, Inc. | -1.3 Million USD | 326198.213% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | 33316.005% |
| Lipocine Inc. | -17.93 Million USD | 23757.499% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | 6291.549% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | 5670.459% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | 11241.117% |
| G1 Therapeutics, Inc. | -39.52 Million USD | 10831.945% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | 19051.108% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 831.573% |
| Ocugen, Inc. | -65.53 Million USD | 6573.297% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | 4619.225% |
| Q32 Bio Inc. | -92.1 Million USD | 4705.781% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | 19886.445% |
| Alumis Inc. Common Stock | -158.17 Million USD | 2781.867% |
| Equillium, Inc. | -14.52 Million USD | 29310.963% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | 6897.449% |
| Coya Therapeutics, Inc. | -7.9 Million USD | 53773.652% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | 22586.041% |
| Galera Therapeutics, Inc. | -46.95 Million USD | 9134.985% |
| Evelo Biosciences, Inc. | -108.46 Million USD | 4010.918% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | 35538.686% |
| Dominari Holdings Inc. | -21.79 Million USD | 19562.36% |
| Edesa Biotech, Inc. | -9.22 Million USD | 46095.092% |
| vTv Therapeutics Inc. | -25.5 Million USD | 16734.052% |
| Bio-Techne Corporation | 206.68 Million USD | -1952.396% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | 1183.565% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | -2109.038% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | 3306.919% |
| Candel Therapeutics, Inc. | -38.39 Million USD | 11149.506% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | 2907.404% |
| Nkarta, Inc. | -131.65 Million USD | 3322.192% |
| BioCardia, Inc. | -11.64 Million USD | 36530.917% |
| Iterum Therapeutics plc | -47.46 Million USD | 9036.58% |